202 related articles for article (PubMed ID: 37499518)
1. miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma.
Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Hegazy M; Elballal MS; Mohammed OA; El-Husseiny HM; Midan HM; El-Dakroury WA; Zewail MB; Abdel Mageed SS; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154704. PubMed ID: 37499518
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 and multiple myeloma: small molecule and big function.
Ma J; Liu S; Wang Y
Med Oncol; 2014 Aug; 31(8):94. PubMed ID: 24981236
[TBL] [Abstract][Full Text] [Related]
3. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma.
Allegra A; Ettari R; Innao V; Bitto A
Cells; 2021 Feb; 10(2):. PubMed ID: 33672466
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance.
Puła A; Robak P; Robak T
Curr Med Chem; 2021 Oct; 28(33):6753-6772. PubMed ID: 33949926
[TBL] [Abstract][Full Text] [Related]
5. miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
Tavakoli Pirzaman A; Ebrahimi P; Hasanpour AH; Shakeri M; Babajani B; Pourali Ganji Z; Babaei H; Rahmati A; Hosseinzadeh R; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231202391. PubMed ID: 37728167
[TBL] [Abstract][Full Text] [Related]
6. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma.
Du J; Liu S; He J; Liu X; Qu Y; Yan W; Fan J; Li R; Xi H; Fu W; Zhang C; Yang J; Hou J
Oncotarget; 2015 Jun; 6(17):14993-5007. PubMed ID: 25915427
[TBL] [Abstract][Full Text] [Related]
8. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.
Rastgoo N; Abdi J; Hou J; Chang H
J Hematol Oncol; 2017 Jun; 10(1):121. PubMed ID: 28623912
[TBL] [Abstract][Full Text] [Related]
9. Role of micro-RNAs in drug resistance of multiple myeloma.
Abdi J; Jian H; Chang H
Oncotarget; 2016 Sep; 7(37):60723-60735. PubMed ID: 27494872
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
11. The potential of miRNAs as biomarkers for multiple myeloma.
Rocci A; Hofmeister CC; Pichiorri F
Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
[TBL] [Abstract][Full Text] [Related]
12. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways.
Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; El-Husseiny AA; Khidr EG; Ali EM; Rashed MH; El-Demerdash FE; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154411. PubMed ID: 36921547
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.
Soliman AM; Lin TS; Mahakkanukrauh P; Das S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066062
[TBL] [Abstract][Full Text] [Related]
14. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
[TBL] [Abstract][Full Text] [Related]
15. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
[TBL] [Abstract][Full Text] [Related]
16. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA‑25‑3p inhibits the proliferation and promotes the apoptosis of multiple myeloma cells via targeting the PTEN/PI3K/AKT signaling pathway.
Zi Y; Zhang Y; Wu Y; Zhang L; Yang R; Huang Y
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33448321
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma.
Qin Y; Zhang S; Deng S; An G; Qin X; Li F; Xu Y; Hao M; Yang Y; Zhou W; Chang H; Qiu L
Leukemia; 2017 May; 31(5):1123-1135. PubMed ID: 27857131
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.
Desantis V; Saltarella I; Lamanuzzi A; Melaccio A; Solimando AG; Mariggiò MA; Racanelli V; Paradiso A; Vacca A; Frassanito MA
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349317
[TBL] [Abstract][Full Text] [Related]
20. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
